Back to results
Active, not recruitingPhase 2

A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

NCT06660173

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Accel Research Site - Birmingham Clinical Research Unit

Birmingham, Alabama, United States

+95 additional locations

View on ClinicalTrials.gov